Prostate Cancer

Latest News

CMS issues reimbursement code for PSMA-PET imaging agent Gozellix
CMS issues reimbursement code for PSMA-PET imaging agent Gozellix

July 15th 2025

The level II code A9616 will be effective starting on October 1, 2025.

Carotuximab plus apalutamide demonstrates safety, tolerability in mCRPC
Carotuximab plus apalutamide demonstrates safety, tolerability in mCRPC

July 15th 2025

Study shows favorable outcomes with guideline-based treatment for localized prostate cancer
Study shows favorable outcomes with guideline-based treatment for localized prostate cancer

July 14th 2025

Patient talking with a doctor | Image Credit: © Pcess609 - stock.adobe.com
FDA grants breakthrough device designation for ArteraAI Prostate tool

July 10th 2025

Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
EMBARK: Significant OS gains seen with enzalutamide plus leuprolide in nmHSPC

July 10th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.